Silicone Adhesive Matrix of Verapamil Hydrochloride to Provide pH-Independent Sustained Release Gaurav ToliaS. Kevin Li Research Article 11 September 2013 Pages: 1 - 10
Development and Characterisation of Ursolic Acid Nanocrystals Without Stabiliser Having Improved Dissolution Rate and In Vitro Anticancer Activity Ju SongYancai WangYing Zheng Research Article 11 September 2013 Pages: 11 - 19
Use of Preclinical Dog Studies and Absorption Modeling to Facilitate Late Stage Formulation Bridging for a BCS II Drug Candidate Filippos Kesisoglou Research Article 11 September 2013 Pages: 20 - 28
A Review of the Advancements in Probiotic Delivery: Conventional vs. Non-conventional Formulations for Intestinal Flora Supplementation Mershen GovenderYahya E. ChoonaraViness Pillay Review Article 25 September 2013 Pages: 29 - 43
Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants Thiagarajan MadheswaranRengarajan BaskaranBong Kyu Yoo Research Article 25 September 2013 Pages: 44 - 51
Development and Characterization of Lyophilized Diazepam-Loaded Polymeric Micelles Jiraphong SuksiriworapongTanaporn RungvimolsinDoungdaw Chantasart Research Article 03 October 2013 Pages: 52 - 64
The Effect of Moisture on the Flowability of Pharmaceutical Excipients Allison CrouterLauren Briens Research Article 03 October 2013 Pages: 65 - 74
Preparation and Characterization of an Advanced Medical Device for Bone Regeneration Rossella DoratiClaudia ColonnaBice Conti Research Article 22 October 2013 Pages: 75 - 82
Comments on “Prediction of Drug Solubility in Lipid Mixtures from the Individual Ingredients” Abolghasem JouybanWilliam E. Acree Jr. Brief/Technical Note 22 October 2013 Pages: 83 - 85
Topical Formulations Containing Pimenta pseudocaryophyllus Extract: In Vitro Antioxidant Activity and In Vivo Efficacy Against UV-B-Induced Oxidative Stress Marcela Z. CampaniniDayana L. CustódioSandra R. Georgetti Research Article 19 November 2013 Pages: 86 - 95
Improved Oral Bioavalability of Mebudipine Upon Administration in PhytoSolve and Phosal-Based Formulation (PBF) Samira KhaniFariborz Keyhanfar Research Article 23 October 2013 Pages: 96 - 102
Microscopic Modeling of País Grape Seed Extract Absorption in the Small Intestine Cristian MoralesMarlene RoeckelKatherina Fernández Research Article 25 October 2013 Pages: 103 - 110
Identification of Unknown Impurity of Azelaic Acid in Liposomal Formulation Assessed by HPLC-ELSD, GC-FID, and GC-MS Stanisław HanKatarzyna Karłowicz-BodalskaWitold Musiał Research Article Open access 29 October 2013 Pages: 111 - 120
Preparation and Pharmacokinetic Study of Aprepitant–Sulfobutyl Ether-β-Cyclodextrin Complex Lili RenYu ZhouGuoguang Chen Research Article 29 October 2013 Pages: 121 - 130
Influence of Starting Material Particle Size on Pellet Surface Roughness Srimanta SarkarBee Hwee AngCeline Valeria Liew Research Article 06 November 2013 Pages: 131 - 139
Quality-by-Design: Are We There Yet? Jack CookMaria T. CruañesJohn Crison Research Article 12 November 2013 Pages: 140 - 148
Investigation of Critical Core Formulation and Process Parameters for Osmotic Pump Oral Drug Delivery Shahrzad MissaghiPiyush PatelAli R. Rajabi-Siahboomi Research Article 13 November 2013 Pages: 149 - 160
Formulation and Optimization of Nonionic Surfactants Emulsified Nimesulide-Loaded PLGA-Based Nanoparticles by Design of Experiments Ceyda Tuba Sengel TurkUmut Can OzCanan Hascicek Research Article 13 November 2013 Pages: 161 - 176
Hydrogels Composed of Cyclodextrin Inclusion Complexes with PLGA-PEG-PLGA Triblock Copolymers as Drug Delivery Systems Elham KhodaverdiFarnaz Sadat Mirzazadeh TekieGholamhossein Zohuri Research Article 14 November 2013 Pages: 177 - 188
Development and Validation of a Discriminative Dissolution Method for Atorvastatin Calcium Tablets using in vivo Data by LC and UV Methods J. C. MachadoA. D. LangeN. M. Volpato Research Article 22 November 2013 Pages: 189 - 197
Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 1: Predicting Degradation Related Impurities and Impurity Considerations for Pharmaceutical Dosage Forms Karen M. AlsanteKim Huynh-BaBiren K. Joshi Meeting Report 27 November 2013 Pages: 198 - 212
Novel Self-assembly Endows Human Serum Albumin Nanoparticles with an Enhanced Antitumor Efficacy Dawei DingXiaolei TangYiqiao Hu Research Article 28 November 2013 Pages: 213 - 222
Physicochemical Characterization of 9-Aminocamptothecin in Aqueous Solutions Shahidur RahmanDeval PatelMichalakis Savva Research Article 03 December 2013 Pages: 223 - 229
Release Characteristics of Quetiapine Fumarate Extended Release Tablets Under Biorelevant Stress Test Conditions Grzegorz GarbaczAnna KandziWerner Weitschies Research Article 03 December 2013 Pages: 230 - 236
Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 2: Safety Considerations of Impurities in Pharmaceutical Products and Surveying the Impurity Landscape Karen M. AlsanteKim C. Huynh-BaPatrick Jansen Meeting Report 21 December 2013 Pages: 237 - 251